Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05759481 · ClinicalTrials.gov registry record · Phase 2
Prevention of Post-Operative Nausea and Vomiting With Propofol Infusion
A Phase 2 study, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 68
- Enrollment target
NCT05759481 is a Phase 2 study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 68 participants.
The verdict
NCT05759481, a Phase 2 study, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 68 participants
- Enrollment target
Study Summary
The purpose of this study is to clarify whether or not a low-dose propofol infusion can effectively prevent postoperative nausea and vomiting (PONV) in patients who have a documented history of PONV and/or motion sickness.
Interventions
- OTHER Placebo
- DRUG Propofol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2024-02-01 |
| Est. Completion | 2025-03-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05759481
The ClinicalTrials.gov registry entry for NCT05759481 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05759481 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05759481 about?
NCT05759481 is a clinical study titled "Prevention of Post-Operative Nausea and Vomiting With Propofol Infusion". The purpose of this study is to clarify whether or not a low-dose propofol infusion can effectively prevent postoperative nausea and vomiting (PONV) in patients who have a documented history of PONV and/or motion sickness.
What is the current status of trial NCT05759481?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 68 participants. The study started on 2024-02-01. Estimated completion is 2025-03-12.
What interventions are being tested in trial NCT05759481?
The interventions under investigation include: Placebo (OTHER), Propofol (DRUG).
Who is sponsoring clinical trial NCT05759481?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.